AU2003271568A1 - Diagnostic and therapeutic use of thyroid hormone binding protein for neurodegenerative diseases - Google Patents
Diagnostic and therapeutic use of thyroid hormone binding protein for neurodegenerative diseasesInfo
- Publication number
- AU2003271568A1 AU2003271568A1 AU2003271568A AU2003271568A AU2003271568A1 AU 2003271568 A1 AU2003271568 A1 AU 2003271568A1 AU 2003271568 A AU2003271568 A AU 2003271568A AU 2003271568 A AU2003271568 A AU 2003271568A AU 2003271568 A1 AU2003271568 A1 AU 2003271568A1
- Authority
- AU
- Australia
- Prior art keywords
- diagnostic
- binding protein
- neurodegenerative diseases
- therapeutic use
- thyroid hormone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- G01N33/78—Thyroid gland hormones, e.g. T3, T4, TBH, TBG or their receptors
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/07—Animals genetically altered by homologous recombination
- A01K2217/072—Animals genetically altered by homologous recombination maintaining or altering function, i.e. knock in
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
- G01N2800/2821—Alzheimer
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02019557.4 | 2002-09-02 | ||
EP02019557 | 2002-09-02 | ||
US40724902P | 2002-09-03 | 2002-09-03 | |
US60/407,249 | 2002-09-03 | ||
PCT/EP2003/009536 WO2004020666A2 (en) | 2002-09-02 | 2003-08-28 | Diagnostic and therapeutic use of thyroid hormone binding protein for neurodegenerative diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2003271568A1 true AU2003271568A1 (en) | 2004-03-19 |
Family
ID=56290477
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003271568A Abandoned AU2003271568A1 (en) | 2002-09-02 | 2003-08-28 | Diagnostic and therapeutic use of thyroid hormone binding protein for neurodegenerative diseases |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1534856A2 (en) |
AU (1) | AU2003271568A1 (en) |
WO (1) | WO2004020666A2 (en) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4980281A (en) * | 1988-02-10 | 1990-12-25 | Housey Gerard M | Method of screening for protein inhibitors and activators |
WO2000067033A1 (en) * | 1999-05-03 | 2000-11-09 | Evotec Biosystems Ag | Methods of diagnosing or treating alzheimer's disease |
US20040053265A1 (en) * | 2000-08-24 | 2004-03-18 | Rainer Hipfel | Diagnostic and therapeutic use of a caveolae-associated integral membrane protein for alzheimer's disease and related neurodegenerative disorders |
AU2002212233A1 (en) * | 2000-09-13 | 2002-03-26 | Evotec Neurosciences Gmbh | Diagnostic and therapeutic use of a phosphoprotein enriched in astrocytes for alzheimer's disease and related neurodegenerative disorders |
WO2002057496A2 (en) * | 2001-01-18 | 2002-07-25 | Socratech L.L.C. | Gene expression profiling of endothelium in alzheimer's disease |
-
2003
- 2003-08-28 WO PCT/EP2003/009536 patent/WO2004020666A2/en not_active Application Discontinuation
- 2003-08-28 AU AU2003271568A patent/AU2003271568A1/en not_active Abandoned
- 2003-08-28 EP EP03753364A patent/EP1534856A2/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
WO2004020666A2 (en) | 2004-03-11 |
WO2004020666A3 (en) | 2004-09-02 |
EP1534856A2 (en) | 2005-06-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003264256A1 (en) | A nutritional and therapeutic composition of an insulin sensitizer and a peptide fraction | |
AU2003239531A1 (en) | Protein cages for the delivery of medical imaging and therapy | |
IL214262A0 (en) | Therapeutic human anti-il-1r1 monoclonal antibody | |
AU2002952993A0 (en) | Therapeutic and diagnostic agents | |
AU2003267532A1 (en) | PEPTIDES AND PEPTIDE DERIVATIVES FOR THE TREATMENT OF Alpha-SYNUCLEIN-RELATED DISEASES | |
AU2002352170A1 (en) | Anti-t cell immunotoxin fusion protein and its therapeutic use | |
AU2003246380A1 (en) | Diagnostic and therapeutic use of tb2 gene and protein for neurodegenerative diseases | |
AU2003260301A1 (en) | Diagnostic and therapeutic use of ensadin-0581 gene and protein for neurodegenerative diseases | |
AU2003278497A1 (en) | Diagnostic and therapeutic use of ras-gtpase-activating sh3-domain-binding protein 2 (g3bp2) for neurodegenerative diseases | |
AU2003246592A1 (en) | Tumour marker and the use thereof for the diagnosis and treatment of tumour diseases | |
AU2002364501A1 (en) | Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer | |
AU2003279312A1 (en) | Diagnostic and therapeutic use of ensadin-0289 gene and protein for neurodegenerative diseases | |
AU2003257398A8 (en) | Composite peptide compounds for diagnosis and treatment of diseases caused by prion proteins | |
AU2003271568A1 (en) | Diagnostic and therapeutic use of thyroid hormone binding protein for neurodegenerative diseases | |
AU2003224080A1 (en) | Diagnostic and therapeutic use of a golgi protein for neurodegenerative diseases | |
AU2003240746A1 (en) | Diagnostic and therapeutic use of steroidogenic acute regulatory protein for neurodegenerative diseases | |
AU2003260460A1 (en) | Diagnostic and therapeutic use of foap-13 polynucleotides and polypeptides for neurodegenerative diseases | |
AU2003242588A1 (en) | Diagnostic and therapeutic use of cyp11a1 for neurodegenerative diseases | |
AU2003288127A1 (en) | DIAGNOSTIC AND THERAPEUTIC USE OF H-Rev107 PROTEIN FOR ALZHEIMER DISEASE | |
AU2003222849A1 (en) | Diagnostic and therapeutic use of ensadin-0255 gene and protein for neurodegenerative diseases | |
AU2003235635A1 (en) | Diagnostic and therapeutic use of the voltage-gated ion channel scn2a for neurodegenerative diseases | |
AU2003232200A1 (en) | Diagnostic and therapeutic use of vault polynucleotides and proteins for neurodegenerative diseases | |
AU2003244645A1 (en) | Diagnostic and therapeutic use of a rab family gtp-binding protein for neurodegenerative diseases | |
AU2003224095A1 (en) | Diagnostic and therapeutic use of an atp-binding cassette gene and protein for neurodegenerative diseases | |
AU2003214075A1 (en) | Diagnostic and therapeutic use of ma onconeuronal antigens for neurodegenerative diseases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |